HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design.

Abstract
Glycoconjugate vaccines have provided enormous health benefits globally, but they have been less successful in some populations at high risk for developing disease. To identify new approaches to enhancing glycoconjugate effectiveness, we investigated molecular and cellular mechanisms governing the immune response to a prototypical glycoconjugate vaccine. We found that in antigen-presenting cells a carbohydrate epitope is generated upon endolysosomal processing of group B streptococcal type III polysaccharide coupled to a carrier protein. In conjunction with a carrier protein-derived peptide, this carbohydrate epitope binds major histocompatibility class II (MHCII) and stimulates carbohydrate-specific CD4(+) T cell clones to produce interleukins 2 and 4-cytokines essential for providing T cell help to antibody-producing B cells. An archetypical glycoconjugate vaccine that we constructed to maximize the presentation of carbohydrate-specific T cell epitopes is 50-100 times more potent and substantially more protective in a neonatal mouse model of group B Streptococcus infection than a vaccine constructed by methods currently used by the vaccine industry. Our discovery of how glycoconjugates are processed resulting in presentation of carbohydrate epitopes that stimulate CD4(+) T cells has key implications for glycoconjugate vaccine design that could result in greatly enhanced vaccine efficacy.
AuthorsFikri Y Avci, Xiangming Li, Moriya Tsuji, Dennis L Kasper
JournalNature medicine (Nat Med) Vol. 17 Issue 12 Pg. 1602-9 (Nov 20 2011) ISSN: 1546-170X [Electronic] United States
PMID22101769 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Epitopes, T-Lymphocyte
  • Glycoconjugates
  • Histocompatibility Antigens Class II
  • Immunoglobulin G
  • Interleukin-2
  • Polysaccharides, Bacterial
  • Vaccines
  • streptococcal polysaccharide type III group B
  • Interleukin-4
Topics
  • Adaptive Immunity
  • Animals
  • Antigen-Presenting Cells (immunology)
  • CD4-Positive T-Lymphocytes (immunology, metabolism)
  • Cell Line
  • Cell Proliferation
  • Epitopes, T-Lymphocyte (immunology)
  • Female
  • Glycoconjugates (immunology, metabolism)
  • Histocompatibility Antigens Class II (immunology, metabolism)
  • Humans
  • Immunization
  • Immunoglobulin G (blood, metabolism)
  • Interleukin-2 (biosynthesis)
  • Interleukin-4 (biosynthesis)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Polysaccharides, Bacterial (metabolism)
  • Vaccines (chemical synthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: